Gender differences in serum GH and IGF-I levels and the GH response to dynamic tests in patients with acromegaly

Endocrine Journal

Volumn 57, Issue 6, 2010, Pages 477-483

  Tanaka, Satoshi ^a   Fukuda, Izumi ^a   Hizuka, Naomi ^a   Takano, Kazue ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Acromegaly; Dynamic test; Gender

Indexed keywords

BROMOCRIPTINE; GROWTH HORMONE; OCTREOTIDE; SEX HORMONE; SOMATOMEDIN C; HUMAN GROWTH HORMONE; PROTIRELIN;

ACROMEGALY; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE RESPONSE; HUMAN; LOADING TEST; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PROTEIN BLOOD LEVEL; PROTIRELIN TEST; SEX DIFFERENCE; BLOOD; DIAGNOSTIC USE; GLUCOSE TOLERANCE TEST; METABOLISM; MIDDLE AGED; RETROSPECTIVE STUDY; SEXUAL DEVELOPMENT; VERY ELDERLY;

ACROMEGALY; ADULT; AGED; AGED, 80 AND OVER; BROMOCRIPTINE; FEMALE; GLUCOSE TOLERANCE TEST; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; OCTREOTIDE; RETROSPECTIVE STUDIES; SEX CHARACTERISTICS; THYROTROPIN-RELEASING HORMONE;

EID: 77954737756     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K09E-342     Document Type: Article

References (23)

1. Clemmons DR, Van Wyk JJ, Ridgway EC, Kliman B, Kjellberg RN, Underwood LE. (1979) Evaluation of ac- romegaly by radioimmunoassay of somatomedin-C. N Engl J Med 301: 1138-1142.
2. Barkan AL, Beitins IZ, Kelch RP (1988) Plasma insu-lin-like growth factor-I/somatomedin-C in acromegaly: correlation with the degree of growth hormone hyper- secretion. J Clin Endocrinol Metab 67: 69-73.
3. van den Berg G, Veldhuis JD, Frolich M, Roelfsema F. (1996) An amplitude-specific divergence in the pul- satile mode of growth hormone (GH) secretion under- lies the gender difference in mean GH concentrationsin men and premenopausal women. J Clin Endocrinol Metab 81: 2460-2467.
4. Landin-Wilhelmsen K, Wilhelmsen L, Lappas G, Rosen T, Lundberg PA, Bengtsson BA. (1994) Serum insulin-like growth factor I in a random population sample of men and women: relation to age, sex, smok-ing habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fi- brinogen, parathyroid hormone and osteocalcin. ClinEndocrinol 41: 351-357.
5. Drake WM, Coyte D, Camacho-Hubner C, Jivanji NM, Kaltsas G, Wood DF, Trainer PJ, Grossman AB, Besser GM, Monson JP. (1998) Optimizing growth hormone replacement therapy by dose titration in hypopituitaryadults. J Clin Endocrinol Metab 83: 3913-3919.
6. Burman P, Johansson AG, Siegbahn A, Vessby B, Karlsson FA. (1997) Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women. J Clin Endocrinol Metab 82: 550-555.
7. Edén Engström B, Burman P, Karlsson FA (2002) Menwith acromegaly need higher doses of octreotide than women. Clin Endocrinol 56: 73-77.
8. Tanaka T, Tachibana K, Shimatsu A, Katsumata N, Tsushima T, Hizuka N, Fujieda K, Yokoya S, Irie M. (2005) A nationwide attempt to standardize growth hormone assays. Horm Res 64: 6-11.
9. Shimatsu A, Chihara K, Hizuka N, Teramoto A, Tanaka T, Tatsumi K, Tachibana K, Katsumata N, Yokoya S, Fujieda K. (2007) Reference intervals of serum insu-lin-like growth factor-I in adult Japanese population:calculated with LMS methods. Horumon To Rinsho(Clinical endocrinology) 55: 393-399. (in Japanese)
10. Ho KY, Evans WS, Blizzard RM, Veldhuis JD, Merriam GR, Samojlik E, Furlanetto R, Rogol AD, Kaiser DL, Thorner MO. (1987) Effects of sex and ageon the 24-hour profile of growth hormone secretion inman: importance of endogenous estradiol concentra-tions. J Clin Endocrinol Metab 64(1): 51-58.
11. Veldhuis JD (1996) Gender differences in secretory ac-tivity of the human somatotropic (growth hormone)axis. Eur J Endocrinol 134: 287-295.
12. Jaffe CA, Ocampo-Lim B, Guo W, Krueger K, Sugahara I, DeMott-Friberg R, Bermann M, Barkan AL. (1998) Regulatory mechanisms of growth hormonesecretion are sexually dimorphic. J Clin Invest 102(1):153-164.
13. Parkinson C, Ryder WDJ, Trainer PJ (2001) The rela-tionship between serum GH and serum IGF-I is gen-der-specific. J Clin Endocrinol Metab 86: 5240-5244.
14. Parkinson C, Renehan AG, Ryder WD, O'Dwyer ST, Shalet SM, Trainer PJ. (2002) Gender and age influ-ence the relationship between serum GH and IGF-I inpatients with acromegaly. Clin Endocrinol (Oxf)57(1):59-64.
15. Jørgensen JO, Christensen JJ, Vestergaard E, Fisker S, Ovesen P, Christiansen JS. (2005) Sex steroids and thegrowth hormone/insulin-like growth factor-I axis inadults. Horm Res 64 (Suppl 2): 37-40.
16. Leung KC, Doyle N, Ballesteros M, Sjogren K, Watts CK, Low TH, Leong GM, Ross RJ, Ho KK. (2003) Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated bySOCS-2. Proc Natl Acad Sci USA 100(3): 1016-1021.
17. Hobbs CJ, Plymate SR, Rosen CJ, Adler RA. (1993) Testosterone administration increases insulin-likegrowth factor-I levels in normal men. J Clin Endocrinol Metab 77(3): 776-779.
18. Colao A, Amato G, Pedroncelli AM, Baldelli R, Grottoli S, Gasco V, Petretta M, Carella C, Pagani G, Tambura G, Lombardi G. (2002) Gender- and age-relat-ed differences in the endocrine parameters of acromeg-aly. J Endocrinol Invest 25(6): 532-538.
19. Chapman IM, Hartman ML, Straume M, Johnson ML, Veldhuis JD, Thorner MO. (1994) Enhanced sensitiv-ity growth hormone (GH) chemiluminescence assayreveals lower postglucose nadir GH concentrationsin men than women. J Clin Endocrinol Metab 78(6):1312-1319.
20. Markkanen H, Pekkarinen T, Välimäki MJ, Alfthan H, Kauppinen-Mäkelin R, Sane T, Stenman UH. (2006) Effect of sex and assay method on serum concentra-tions of growth hormone in patients with acromegalyand in healthy controls. Clin Chem 52(3): 468-473.
21. Arafat AM, Möhlig M, Weickert MO, Perschel FH, Purschwitz J, Spranger J, Strasburger CJ, Schöfl C, Pfeiffer AF. (2008) Growth hormone response duringoral glucose tolerance test: the impact of assay methodon the estimation of reference values in patients withacromegaly and in healthy controls, and the role ofgender, age, and body mass index. J Clin EndocrinolMetab 93(4): 1254-1262.
22. Freda PU, Landman RE, Sundeen RE, Post KD. (2001) Gender and age in the biochemical assessment of cureof acromegaly. Pituitary 4(3): 163-171.
23. Cazabat L, Souberbielle JC, Chanson P. (2008) Dynamic tests for the diagnosis and assessment oftreatment efficacy in acromegaly. Pituitary 11(2): 129-139.